GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027.  Currently, 27 products are IVDR cleared, with 16 that are Notified Body certified in class C and B. These include tests for infectious diseases and immuno-compromised/transplant.

SALEM, NH, June 15, 2023 - American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay.

BRNO, CZECH REPUBLIC, April 17, 2023 – ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust supply chain and support systems.

SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr. Allen will assume leadership of all aspects of the ALPCO-GeneProof organization in the United States and Europe.

In April of this year, ALPCO proudly announced its merger with GeneProof. Together we are a global leader in immunodiagnostics and molecular diagnostics providing you, our customers, with reagents and proprietary automated sample-to-answer solutions for the tests that matter most to you. Through the depth and breadth of our respective portfolios, ALPCO and GeneProof provide you with t...

Skip the crowd! Reserve you own one-on-one appointment at AACC for a personalized demo. Schedule here. Featuring New and Exclusive Automated Platforms for Molecular Dx myCROBE is your PCR Laboratory on the Table A fully automated sample-to-result solution for molecular diagnostics with a broad spectrum of diagnostic tests. croBEE 2.0 Nucleic Acid Extraction System is a...

SALEM, NH and BRNO, Czech Republic – April 21st, 2022: American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader in the diagnostic products market, with broad capabilities spanning ...

FOR IMMEDIATE RELEASE – ALPCO’s Winter 2022 Diabetes Research Travel Grant has been awarded to Anoop Arunagiri, PhD, a Research Investigator at the University of Michigan.

Dr. Arunagiri’s research is centered on studying proinsulin misfolding in pancreatic beta cells, and delineating the events and factors contributing to misfolding in the context of diabetes.

ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an unlimited match to all its employees’ contributions to humanitarian aid organizations. As of March 14, ...